QSS
Quantitative Systematic Strategies Portfolio holdings
AUM
$11.5M
This Quarter Return
+25.28%
1 Year Return
+21.99%
3 Year Return
+132.84%
5 Year Return
+157.46%
10 Year Return
–
AUM
$506M
AUM Growth
+$506M
(+314%)
Cap. Flow
+$361M
Cap. Flow
% of AUM
71.37%
Top 10 Holdings %
Top 10 Hldgs %
9.45%
Holding
641
New
400
Increased
138
Reduced
26
Closed
76
Top Buys
| 1 |
Mondelez International
MDLZ
|
$4.31M |
| 2 |
Procter & Gamble
PG
|
$4.28M |
| 3 |
Bristol-Myers Squibb
BMY
|
$3.49M |
| 4 |
Archer Daniels Midland
ADM
|
$3.44M |
| 5 |
Baxter International
BAX
|
$3.4M |
Top Sells
| 1 |
Allstate
ALL
|
$1.27M |
| 2 |
RTX Corp
RTX
|
$1.27M |
| 3 |
Medtronic
MDT
|
$1.2M |
| 4 |
Centene
CNC
|
$991K |
| 5 |
Duke Energy
DUK
|
$952K |
Sector Composition
| 1 | Healthcare | 18.67% |
| 2 | Financials | 16.28% |
| 3 | Technology | 15.39% |
| 4 | Industrials | 10.01% |
| 5 | Consumer Staples | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Union Pacific
UNP
$132B
| $2.72M | 0.54% |
16,075
+11,082
| +222% | +$1.87M |
|
27
American Financial Group
AFG
$11.5B
| $2.69M | 0.53% |
+42,374
| New | +$2.69M |
|
28
Linde
LIN
$221B
| $2.65M | 0.52% |
12,500
+9,625
| +335% | +$2.04M |
|
|
NVRO
29
DELISTED
NEVRO CORP.
NVRO
| $2.65M | 0.52% |
22,155
+14,528
| +190% | +$1.74M |
|
|
LHCG
30
DELISTED
LHC Group LLC
LHCG
| $2.64M | 0.52% |
15,168
+10,583
| +231% | +$1.84M |
|
31
Healthcare Realty
HR
$6.13B
| $2.64M | 0.52% |
+99,471
| New | +$2.64M |
|
32
NXP Semiconductors
NXPI
$57.5B
| $2.61M | 0.52% |
22,921
+19,017
| +487% | +$2.17M |
|
33
Amazon
AMZN
$2.41T
| $2.6M | 0.51% |
942
-69
| -7% | -$190K |
|
34
JPMorgan Chase
JPM
$824B
| $2.59M | 0.51% |
27,558
+19,975
| +263% | +$1.88M |
|
35
Fortive
FTV
$15.9B
| $2.53M | 0.5% |
37,371
+13,436
| +56% | +$909K |
|
36
Quest Diagnostics
DGX
$20.1B
| $2.52M | 0.5% |
22,105
+16,696
| +309% | +$1.9M |
|
37
Walmart
WMT
$793B
| $2.52M | 0.5% |
21,030
+17,410
| +481% | +$2.09M |
|
38
Moody's
MCO
$89B
| $2.48M | 0.49% |
+9,032
| New | +$2.48M |
|
39
Goldman Sachs
GS
$221B
| $2.4M | 0.47% |
12,120
+5,809
| +92% | +$1.15M |
|
40
Arch Capital
ACGL
$34.7B
| $2.37M | 0.47% |
82,750
+73,974
| +843% | +$2.12M |
|
41
Intel
INTC
$105B
| $2.35M | 0.46% |
39,217
+24,472
| +166% | +$1.46M |
|
42
AstraZeneca
AZN
$255B
| $2.34M | 0.46% |
44,304
+28,103
| +173% | +$1.49M |
|
43
Truist Financial
TFC
$59.8B
| $2.34M | 0.46% |
62,194
+44,866
| +259% | +$1.68M |
|
44
Chubb
CB
$111B
| $2.28M | 0.45% |
+18,017
| New | +$2.28M |
|
45
Micron Technology
MU
$133B
| $2.25M | 0.45% |
43,718
+19,432
| +80% | +$1M |
|
46
Parker-Hannifin
PH
$94.8B
| $2.25M | 0.44% |
+12,252
| New | +$2.25M |
|
47
TSMC
TSM
$1.2T
| $2.24M | 0.44% |
+39,462
| New | +$2.24M |
|
|
CTLT
48
DELISTED
CATALENT, INC.
CTLT
| $2.2M | 0.44% |
30,072
+10,454
| +53% | +$766K |
|
49
Boston Properties
BXP
$11.7B
| $2.18M | 0.43% |
+24,112
| New | +$2.18M |
|
50
Cannae Holdings
CNNE
$1.09B
| $2.17M | 0.43% |
52,893
+46,122
| +681% | +$1.9M |
|